Drug intelligence / Profile preview

genistein combined polysaccharide

Development stage
Phase 3
Lead developer
Amino Up
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Genistein Combined Polysaccharide (GCP) is a proprietary botanical extract produced by the fermentation of soy isoflavones with shiitake mushroom (*Lentinula edodes*) mycelia. This unique fermentation process utilizes mushroom-derived enzymes to convert genistin, the glycoside form of genistein found in soy, into its more bioavailable aglycone form, genistein. The resulting mixture also contains mushroom-derived polysaccharides, primarily alpha-glucans. GCP has been primarily investigated for its potential chemopreventive and therapeutic effects in oncology, particularly for prostate cancer. It is hypothesized to inhibit tumor growth and reduce prostate-specific antigen (PSA) levels through multiple mechanisms, including the inhibition of protein-tyrosine kinases, induction of apoptosis, and modulation of the immune system.

Brand names
GCP
Other names
Genistein Concentrated Polysaccharide
02

Targets

Androgen receptor / filamin A signaling complexTOP2A (DNA topoisomerase II)ESR1 (ERα)ESR2 (ERβ)PRR (Pattern recognition receptors)RTK (Receptor protein-tyrosine kinase)

Beyond the preview

Go deeper on genistein combined polysaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on genistein combined polysaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call